Quality of life, resource consumption and costs of spinal cord stimulation versus conventional medical management in neuropathic pain patients with failed back surgery syndrome (PROCESS trial)

Background: Chronic back and leg pain conditions result in patients’ loss of function, reduced quality of life and increased costs to the society.

[1]  S. Wilson.  Methods for the economic evaluation of health care programmes , 1987 .

[2]  D. Thompson.  British National Formulary (BNF) , 2005 .

[3]  E. Buchser,et al.  THE EFFECTS OF SPINAL CORD STIMULATION IN NEUROPATHIC PAIN ARE SUSTAINED: A 24‐MONTH FOLLOW‐UP OF THE PROSPECTIVE RANDOMIZED CONTROLLED MULTICENTER TRIAL OF THE EFFECTIVENESS OF SPINAL CORD STIMULATION , 2008, Neurosurgery.

[4]  D. Carroll,et al.  Epidemiology and treatment of neuropathic pain: The UK primary care perspective , 2006, PAIN.

[5]  C Roberts,et al.  Baseline imbalance in randomised controlled trials , 1999, BMJ.

[6]  Blair H. Smith,et al.  The epidemiology of chronic pain of predominantly neuropathic origin. Results from a general population survey. , 2006, The journal of pain : official journal of the American Pain Society.

[7]  D. Kidd,et al.  Prognostic value of psychological testing in patients undergoing spinal cord stimulation: a prospective study. , 1996, Neurosurgery.

[8]  R. Taylor,et al.  Spinal cord stimulation for failed back surgery syndrome: A decision-analytic model and cost-effectiveness analysis , 2005, International Journal of Technology Assessment in Health Care.

[9]  David J Torgerson,et al.  Effect of regression to the mean on decision making in health care , 2003, BMJ : British Medical Journal.

[10]  Richard North,et al.  The cost effectiveness of spinal cord stimulation in the treatment of pain: a systematic review of the literature. , 2004, Journal of pain and symptom management.

[11]  D. Altman,et al.  Analysing controlled trials with baseline and follow up measurements , 2001, BMJ : British Medical Journal.

[12]  Krishna Kumar,et al.  Treatment of Chronic Pain with Spinal Cord Stimulation versus Alternative Therapies: Cost-effectiveness Analysis , 2002, Neurosurgery.

[13]  B. Spilker,et al.  Quality of life and pharmacoeconomics in clinical trials , 1996 .

[14]  M. Sculpher,et al.  Estimating mean QALYs in trial-based cost-effectiveness analysis: the importance of controlling for baseline utility. , 2005, Health economics.

[15]  M. Luft.  The failed back syndrome; etiology and therapy. , 1984, Orthopedics.

[16]  J. van Zundert.  Clinical Research in Interventional Pain Management Techniques: The Clinician's Point of View , 2007, Pain practice : the official journal of World Institute of Pain.

[17]  Grazyna Adamiak,et al.  Methods for the economic evaluation of health care programmes, 3rd ed , 2006 .

[18]  Nick Freemantle,et al.  The impact of chronic heart failure on health‐related quality of life data acquired in the baseline phase of the CARE‐HF study , 2005, European journal of heart failure.

[19]  E. Buchser,et al.  Spinal Cord Stimulation for Chronic Back and Leg Pain and Failed Back Surgery Syndrome: A Systematic Review and Analysis of Prognostic Factors , 2005, Spine.

[20]  E. Buchser,et al.  Spinal cord stimulation versus conventional medical management for neuropathic pain: A multicentre randomised controlled trial in patients with failed back surgery syndrome , 2007, Pain.

[21]  P Carlsson,et al.  Resource costing for multinational neurologic clinical trials: methods and results. , 1998, Health economics.

[22]  G. Oster,et al.  Clinical characteristics and economic costs of patients with painful neuropathic disorders. , 2004, The journal of pain : official journal of the American Pain Society.

[23]  R. Deyo,et al.  Spinal cord stimulation for patients with failed back surgery syndrome or complex regional pain syndrome: a systematic review of effectiveness and complications , 2004, Pain.

[24]  L. Curtis,et al.  Unit Costs of Health and Social Care 2016 , 2015 .

[25]  D. Long,et al.  Dorsal root ganglionectomy for failed back surgery syndrome: a 5-year follow-up study. , 1991, Journal of neurosurgery.

[26]  Mario Saltarelli,et al.  Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations. , 2003, Archives of neurology.

[27]  A. Briggs,et al.  Something old, something new, something borrowed, something blue: a framework for the marriage of health econometrics and cost-effectiveness analysis. , 2002, Health economics.

[28]  G. Bennett.  Neuropathic pain: new insights, new interventions. , 1998, Hospital practice.

[29]  Jeremy Fairbank,et al.  Surgical stabilisation of the spine compared with a programme of intensive rehabilitation for the management of patients with chronic low back pain: cost utility analysis based on a randomised controlled trial , 2005, BMJ : British Medical Journal.

[30]  M. Sculpher,et al.  Spinal Cord Stimulation vs. Conventional Medical Management: A Prospective, Randomized, Controlled, Multicenter Study of Patients with Failed Back Surgery Syndrome (PROCESS Study) , 2005, Neuromodulation : journal of the International Neuromodulation Society.

[31]  Patrick W. Sullivan,et al.  Preference-Based EQ-5D Index Scores for Chronic Conditions in the United States , 2006, Medical decision making : an international journal of the Society for Medical Decision Making.

[32]  P. Dolan,et al.  Modeling valuations for EuroQol health states. , 1997, Medical care.